Correlation Between Stonebridge Acquisition and Takeda Pharmaceutical

Can any of the company-specific risk be diversified away by investing in both Stonebridge Acquisition and Takeda Pharmaceutical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Stonebridge Acquisition and Takeda Pharmaceutical into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Stonebridge Acquisition Corp and Takeda Pharmaceutical Co, you can compare the effects of market volatilities on Stonebridge Acquisition and Takeda Pharmaceutical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Stonebridge Acquisition with a short position of Takeda Pharmaceutical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Stonebridge Acquisition and Takeda Pharmaceutical.

Diversification Opportunities for Stonebridge Acquisition and Takeda Pharmaceutical

-0.76

Correlation Coefficient

Stonebridge Acquisition  Takeda Pharmaceutical

Pay attention - limited upside

The 3 months correlation between Stonebridge and Takeda is -0.76. Overlapping area represents the amount of risk that can be diversified away by holding Stonebridge Acquisition Corp and Takeda Pharmaceutical Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Takeda Pharmaceutical and Stonebridge Acquisition is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Stonebridge Acquisition Corp are associated (or correlated) with Takeda Pharmaceutical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Takeda Pharmaceutical has no effect on the direction of Stonebridge Acquisition i.e., Stonebridge Acquisition and Takeda Pharmaceutical go up and down completely randomly.

Pair Corralation between Stonebridge Acquisition and Takeda Pharmaceutical

Given the investment horizon of 90 days Stonebridge Acquisition Corp is expected to generate 0.06 times more return on investment than Takeda Pharmaceutical. However, Stonebridge Acquisition Corp is 17.6 times less risky than Takeda Pharmaceutical. It trades about 0.27 of its potential returns per unit of risk. Takeda Pharmaceutical Co is currently generating about 0.0 per unit of risk. If you would invest  1,077  in Stonebridge Acquisition Corp on October 3, 2024 and sell it today you would earn a total of  18.00  from holding Stonebridge Acquisition Corp or generate 1.67% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	9.87%
Values	Daily Returns

Stonebridge Acquisition Corp  vs.  Takeda Pharmaceutical Co

Stonebridge Acquisition

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Stonebridge Acquisition Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound basic indicators, Stonebridge Acquisition is not utilizing all of its potentials. The latest stock price tumult, may contribute to shorter-term losses for the shareholders.

Takeda Pharmaceutical

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Takeda Pharmaceutical Co has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable technical indicators, Takeda Pharmaceutical is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.

Pair Trading with Stonebridge Acquisition and Takeda Pharmaceutical

The main advantage of trading using opposite Stonebridge Acquisition and Takeda Pharmaceutical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Stonebridge Acquisition position performs unexpectedly, Takeda Pharmaceutical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Takeda Pharmaceutical will offset losses from the drop in Takeda Pharmaceutical's long position.

The idea behind Stonebridge Acquisition Corp and Takeda Pharmaceutical Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.